Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 26.04.18 in Vol 4, No 2 (2018): Apr-Jun

This paper is in the following e-collection/theme issue:

Works citing "Public Awareness of Uterine Power Morcellation Through US Food and Drug Administration Communications: Analysis of Google Trends Search Term Patterns"

According to Crossref, the following articles are citing this article (DOI 10.2196/publichealth.9913):

(note that this is only a small subset of citations)

  1. Zepecki A, Guendelman S, DeNero J, Prata N. Using Application Programming Interfaces to Access Google Data for Health Research: Protocol for a Methodological Framework. JMIR Research Protocols 2020;9(7):e16543
  2. Matsushita T, Sekizawa A, Jacobs LK. Racial Disparities in Response to a US Food and Drug Administration Safety Communication Regarding the Use of Power Morcellation for the Treatment of Uterine Leiomyoma. Journal of Minimally Invasive Gynecology 2020;27(1):178
  3. Ciebiera M, Włodarczyk M, Zgliczyński S, Łoziński T, Walczak K, Czekierdowski A. The Role of miRNA and Related Pathways in Pathophysiology of Uterine Fibroids—From Bench to Bedside. International Journal of Molecular Sciences 2020;21(8):3016
  4. Zaami S, Zupi E, Lazzeri L, Stark M, Malvasi A, Signore F, Marinelli E. Medicolegal Issues in Power Morcellation: Cautionary Rules for Gynecologists to Avoid Unfavorable Outcomes. Journal of Minimally Invasive Gynecology 2020;27(3):583
  5. Liou N, Mallick R, Aref-Adib M, Odejinmi F. Google searches and medical publication trends since the 2014 US Food and Drug Administration position on power morcellation: Do these translate into patient awareness?. European Journal of Obstetrics & Gynecology and Reproductive Biology 2019;243:168